Select the Industry/ Sector šŸ‘‰    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,438.8
₹65,029 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹26,643.7
₹56,616 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,395.0
₹30,157 Cr
Pharmaceuticals & Drugs
₹966.7
₹19,001 Cr
Pharmaceuticals & Drugs
₹616.6
₹5,588 Cr
Pharmaceuticals & Drugs
₹488.5
₹4,491 Cr
Pharmaceuticals & Drugs
₹375.2
₹4,196 Cr
Pharmaceuticals & Drugs
₹101.5
₹2,606 Cr
Pharmaceuticals & Drugs
₹1,185.1
₹676 Cr
Pharmaceuticals & Drugs
₹51.9
₹146 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,438.8
₹12,634 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹966.7
₹6,229 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,395.0
₹4,209 Cr
Pharmaceuticals & Drugs
₹488.5
₹2,529 Cr
Pharmaceuticals & Drugs
₹616.6
₹1,853 Cr
Pharmaceuticals & Drugs
₹375.2
₹624 Cr
Pharmaceuticals & Drugs
₹101.5
₹157 Cr
Pharmaceuticals & Drugs
₹26,643.7
₹5,849 Cr
Pharmaceuticals & Drugs
₹1,185.1
₹362 Cr
Pharmaceuticals & Drugs
₹51.9
₹343 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,438.8
₹1,575 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,395.0
₹816 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹966.7
₹617 Cr
Pharmaceuticals & Drugs
₹616.6
₹217 Cr
Pharmaceuticals & Drugs
₹488.5
₹172 Cr
Pharmaceuticals & Drugs
₹375.2
₹137 Cr
Pharmaceuticals & Drugs
₹101.5
₹93 Cr
Pharmaceuticals & Drugs
₹26,643.7
₹1,201 Cr
Pharmaceuticals & Drugs
₹1,185.1
₹75 Cr
Pharmaceuticals & Drugs
₹51.9
₹4 Cr

You may also like the below Video Courses